Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

Haematologica. 2015 Jun;100(6):e240-3. doi: 10.3324/haematol.2014.119214. Epub 2015 Feb 14.

¹ National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Faculty of Medicine, University of Oslo, Norway knusme@ous-hf.no.
² National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway.
³ Department of Oncology, Oslo University Hospital, Norway.
⁴ Department of Oncology, St. Olavs Hospital, Trondheim, Norway Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
⁵ Oslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Norway.
⁶ Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
⁷ National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Department of Behavioural Sciences in Medicine, Faculty of Medicine, University of Oslo, Norway.
⁸ Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
⁹ Faculty of Medicine, University of Oslo, Norway Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Norway.

No abstract available

Keywords: autologous stem cell transplantation; high-dose therapy; mortality; non-Hodgkin lymphoma; survival.

Publication types